AIM ImmunoTech (AIM) announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety of Ampligen in Patients ...
In a report released on January 24, Kenneth Lee from RBC Capital maintained a Buy rating on Ameriprise Financial (AMP – Research Report), with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback